Stay updated on Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FYx2YDW6IIaMCqVc70Vvr3-lOpsA.uncropped.jpg&w=3840&q=75)
Latest updates to the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- ChecktodayChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.3%
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.SummaryDifference6%
- Check50 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.3%
- Check64 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.3%
- Check69 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.3%
Stay in the know with updates to Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.